Tirzepatide Oral 500mcg x 25 tablets

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its interaction with incretin-based metabolic signaling pathways. Research focuses on its coordinated receptor activation and endocrine regulatory effects in experimental models.

FDA Disclaimer: The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The products offered are not intended to diagnose, treat, cure, or prevent any disease. All products are intended for laboratory research use only and are not for human consumption.